An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIII

发表于 2026-9-18 17:11:23

期刊：Journal of Pharmaceutical Sciences

文献作者：Elisabeth Husar; Silke Simon; Afsaneh Abdolzade-Bavil; Angelique Augustin; Miro J. Eigenmann; Anne Freimoser-Grundschober; Alina Gavrilov; Reto Gianotti; Nikolche Gjorevski; Patricio Godoy; Andreas Hollenstein; Martin Lechmann; Valeria G. Nicolini; Liudmila Polonchuk; Nadine Stokar-Regenscheit; Roberto Villasenor; Cornelia Wagner; Inja Waldhauer; Antje-Christine Walz

出版日期：2026-2-

DOI号：10.1016/j.xphs.2025.104112

下载链接：https://www.sciencedirect.com/sc ... 022354925005660/pdf

文献链接：https://doi.org/10.1016/j.xphs.2025.104112

当前文献来源于 Elsevier BV。

备注信息：

发表于 2026-9-18 17:11:24

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Elsevier/Sciencedirect] An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIII

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIII 一键复制